Deutsche medizinische Wochenschrift (1946), 2015-07, Vol.140 (14), p.1051
2015
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Non-alcoholic fatty liver disease (NAFLD)
- Ist Teil von
- Deutsche medizinische Wochenschrift (1946), 2015-07, Vol.140 (14), p.1051
- Ort / Verlag
- Germany
- Erscheinungsjahr
- 2015
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Non-alcoholic fatty liver disease is the most common chronic liver disease in Europe and in the USA with rising prevalence. Patients with a metabolic syndrome (diabetes mellitus, obesity, dyslipidemia) are patients at risk with the highest prevalence for NAFLD. Progression from a non-alcoholic fatty liver (NAFL) to a non-alcoholic steatohepatitis (NASH) occurs in 5-20% of patients with the potential to develop a liver fibrosis/cirrhosis. NASH patients and NAFLD patients with higher fibrosis should be identified because they are at risk of a higher mortality. A specific treatment for NASH is not available at the moment. Therefore, the treatment of risk factors and metabolic syndrome has high priority.
- Sprache
- Deutsch
- Identifikatoren
- eISSN: 1439-4413DOI: 10.1055/s-0041-102787Titel-ID: cdi_pubmed_primary_26182253
- Format
- –
- Schlagworte
- Comorbidity, Diabetes Mellitus - diagnosis, Diabetes Mellitus - epidemiology, Diabetes Mellitus - prevention & control, Disease Progression, Dyslipidemias - diagnosis, Dyslipidemias - epidemiology, Dyslipidemias - prevention & control, Humans, Internationality, Metabolic Syndrome - diagnosis, Metabolic Syndrome - epidemiology, Metabolic Syndrome - prevention & control, Non-alcoholic Fatty Liver Disease - diagnosis, Non-alcoholic Fatty Liver Disease - epidemiology, Non-alcoholic Fatty Liver Disease - therapy, Obesity - diagnosis, Obesity - epidemiology, Obesity - prevention & control, Prevalence, Risk Factors